Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding trial of topical resiquimod gel for multiple actinic keratosis lesions
2011-003943-23Phase 2Completed
- Sponsor
- Galderma
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of resiquimod in actinic keratosis (AK) (6 arms), sponsored by Galderma. Primary endpoint: Number of patients with complete clinical clearance. Started Nov 2011; status: completed.
02
Drugs
resiquimod
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2011-003943-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003943-23.